Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92103


Purpose:

The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved medication for the treatment of angina, on heart function by using echocardiography.


Criteria:

Inclusion Criteria: - Moderate of severe diastolic dysfunction, E/Ea>12 - Preserved systolic function - NYHA Class I-II Exclusion Criteria: - QTc >450 msec at enrollment - Taking medications that prolong QT interval or are potent inhibitors of CYP3A - Significant coronary artery disease - Severe valvular disease - Hepatic disease - Severe kidney disease - Women of childbearing age - Prior serious ventricular arrhythmia


NCT ID:

NCT00574756


Primary Contact:

Principal Investigator
Anthony DeMaria, MD
UCSD Medical Center

Wendy Austin, MD
Phone: 619-543-8213
Email: waustin@ucsd.edu


Backup Contact:

N/A


Location Contact:

San Diego, California 92103
United States

Wendy Austin, MD
Phone: 619-543-8213
Email: waustin@ucsd.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.